Racial disparities in treatment delay among younger men with prostate cancer

Young men (≤55 years) with prostate cancer (PC) may experience treatment delays despite clinical consequences of delays beyond six months. Using the United States National Cancer Database (2004–2017), we employed multivariable logistic regression analysis to retrospectively examine racial disparities in localized PC treatment delays >6 months since diagnosis. Of the 89,196 men ≤55 years included, young Black men experienced treatment delays beyond six months more frequently than young White men (7.39% vs. 3.96%; AOR 1.95, 95% CI 1.81–2.09, p < 0.001), a disparity that was greater than that among men ages 56–64 ( p interaction < 0.001). This result persisted upon restricting the sample to men with private insurance/managed care. The finding that Black men with localized PC experienced treatment delays almost twice as frequently as White men underscores access barriers that may go beyond the direct costs of care.